Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
Objectives. We aimed to explore the association between metformin treatment and epithelial-mesenchymal transition (EMT) phenotype and further appraise the prognostic values of metformin and EMT markers E-cadherin and vimentin for colorectal cancer (CRC) in clinical practice. Methods. We collected sp...
Saved in:
Main Authors: | Yaodu Wang, Zhiyang Wu, Likuan Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/2520581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin
by: Alex Brandon Wong, et al.
Published: (2023-12-01) -
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
by: Fanqiang Meng, et al.
Published: (2017-01-01) -
Opioid System and Epithelial–Mesenchymal Transition
by: Marzena Łazarczyk, et al.
Published: (2025-01-01) -
PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
by: Ahmed H Ghobashi, et al.
Published: (2024-01-01) -
Skullcapflavone II suppresses TGF-β-induced corneal epithelial mesenchymal transition in vitro
by: Meng-Xi Li, et al.
Published: (2025-02-01)